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Background: Early use of continuous positive airway pressure (CPAP) has been shown to be beneficial within the
setting of acute cardiogenic pulmonary edema (ACPE). The Boussignac CPAP system (BCPAP) was therefore
introduced into the protocols of emergency medical services (EMS) in a large urban region. This study evaluates the
implementation, practical use and complications of this prehospital treatment.
Methods: This was a retrospective case series study. The study was carried out in a period shortly after the
implementation of the BCPAP system on all EMS ambulances in the The Hague region. According to protocol,
diagnosis of ACPE in the prehospital setting was left to the discretion of the EMS paramedics and the facial mask
was applied immediately after the diagnosis had been made. Patients were selected through hospital registration
and diagnostic criteria for ACPE. Only those patients showing evident clinical signs of ACPE were included. Patient
characteristics, physiologic variables, clinical outcomes and complications were collected from EMS transport reports
and hospital records.
Results: Between 1 June 2008 and 30 April 2009 a total of 180 patients were admitted for ACPE. Of these, 76 (42%)
had evident clinical signs of ACPE upon presentation and were included. Three patients were transferred and in 14
cases data were missing. Out of the remaining 59 patients, 16 (27%) received BCPAP. In 43 (73%) cases the mask
was not applied. For 7 out of 43 cases that were eligible for BCPAP treatment but did not receive the facial mask,
an explanation was found in the EMS transport record. No complications were recorded pertaining to using the
BCPAP system.
Conclusions: A significant portion of patients with clinical signs of acute cardiogenic pulmonary edema in the
prehospital setting is not treated according to protocol using BCPAP. Based on the small group of patients that
actually received BCPAP treatment, the facial mask seems feasible and effective for the treatment of acute
cardiogenic pulmonary edema in the prehospital setting.
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Early use of continuous positive airway pressure (CPAP)
has proven to be beneficial in preventing endotracheal
intubation and reducing intensive care unit (ICU) and
coronary care unit (CCU) length of stay within the setting
of acute cardiogenic pulmonary edema (ACPE) [1]. The
Boussignac CPAP (BCPAP) facial mask system is a compact
and flexible CPAP system that can be used by emergency
medical service (EMS) paramedics in the prehospital setting
[2-4]. A prospective study with BCPAP performed at a cor-
onary care unit in The Netherlands reported a 14 per cent
decrease in the number of endotracheal intubations, 25 per
cent decrease in ICU admissions, 50 per cent decrease in
ICU length of stay and 50 per cent decrease in median
hospital length of stay [5]. Several studies also showed that
the early use of CPAP in the prehospital setting was associ-
ated with a better outcome [5]. Regional implementation of
the BCPAP system into the standard ACPE protocols of the
emergency medical services took place recently. The aim of
this study was to evaluate the use, effects and complications
of the BCPAP protocol following implementation into the
regional EMS of The Hague, The Netherlands.
Methods
This was a retrospective observational case series study.
The Boussignac CPAP system
The Boussignac CPAP system is a simple, safe, cheap
and lightweight (10 g) plastic cylinder that is directly
connected to a disposable face mask (Figure 1 [6]) and has
been shown to be effective for ACPE in the emergency
department and in prehospital care [2-4]. The Boussignac
system provides continuous positive airway pressure by
injecting oxygen at high speed into a cylinder through
curved side channels. The resulting turbulence in combin-
ation with air friction drives air into the cylinder, causing itFigure 1 Application of the Boussignac CPAP mask.to flow along the insides of the cylinder (Figure 2
[7]). The system is lightweight because there is no
need for ventilators or machines with main connection or
heavy tubing. An oxygen flow of 15 l/min was used to
generate a pressure of 5 cm H2O.
Setting
This study was performed at the Haga Hospital and
regional EMS organisations in The Hague, The Netherlands.
The emergency department (ED) has an annual visit
of 45,000 patients, cooperates with two regional EMSs
and covers a rural and industrial area with a popula-
tion of ±500,000 [8]. BCPAP was officially introduced on
all EMSs in June 2008. All EMS paramedics participated in
an extensive practical training and two E-learnings on
using the mask. Indications and contraindications for
using the BCPAP were discussed. Contraindications for
applying the mask were decreased consciousness, facial
trauma and anatomical variations (e.g. tracheotomy,
bearded men) that made application of the mask impos-
sible. All EMS ambulances in the region were equipped
with the disposable BCPAP system with different mask
sizes. Application of the BCPAP mask was left to the dis-
cretion of the EMS paramedics. All patients were treated
on an intention-to-treat basis and received diuretics and va-
sodilators according to protocol. This study was reviewed
and approved by our institutional research board. The na-
tional EMS protocol for acute cardiogenic pulmonary
edema is shown in Figure 3.
Study design
We used hospital registration to select all patients diag-
nosed with ACPE upon presentation at the emergency
department from 1 June 2008 until 30 April 2009. We ex-
cluded those cases that did not meet all ACPE criteria, i.e.
acute dyspnoea within the preceding 24 h, or acute worsen-
ing of dyspnoea and crepitations of both lungs upon aus-
cultation. All vital parameters were retrieved from the EMS
ambulance transport records. Diagnostic and therapeutic
considerations from EMS personnel were also recorded.
Outcome measures
Primary outcome parameters were the number and
percentage of eligible ACPE patients that were treated
using the BCPAP system within the prehospital setting.
Secondary outcome parameters were complications
(aspiration, mask discomfort or pain), feasibility of mask
application, changes in physiologic variables, endotracheal
intubation rate, ICU, CCU and hospital lengths of stay,
and hospital mortality.
Primary data analysis
Statistical analysis was performed using SPSS 16.0.01,
SPSS, Chicago, IL, USA.
Figure 2 Direction of the oxygen flow in the Boussignac CPAP mask.
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distribution, we used nonparametric tests for the
statistical analysis. We used the Mann–Whitney U
test to analyse numerical data, the chi-square test or
Fisher’s exact test (when a cell count was less than
five) for categorical data. Significance level was set as
p < 0.05. Power analyses were not performed for
secondary measures.
Results
Main outcomes
Between 1 June 2008 and 30 April 2009, 180 patients
were diagnosed with ACPE upon admission. Seventy-
six cases met our ACPE criteria. Three patients were
transferred and in 14 cases data were missing. Of the
remaining 59 patients, 16 (27%) received BCPAP be-
fore arrival at the emergency department. In 43 (73%)
cases, the mask was not applied (Figure 4). For 7 out
of 43 cases that were eligible for BCPAP treatment
but did not receive the facial mask, an explanation
was found in the EMS transport record. In two cases
problems were noted in the practical use, in three
cases the mask was not applied because the patient
was agitated, and in two cases there were patient-
related contraindications, i.e. tracheotomy and a nose-
bleed. In the remaining 36 cases no explanation was
given for not giving BCPAP in the prehospital setting.No adverse effects (e.g. facial skin injury, pneumo-
thorax) related to the BCPAP were noted during
this study.
Explanations for failed BCPAP administration
In 7 cases BCPAP treatment was not administered and
an explanation was found in the EMS transport records.
Twice the explanation referred to a dysfunctional sys-
tem (i.e. ‘system is not working’ and ‘system leaks at
tank’). Twice the EMS personnel stated that the patient
was too agitated to accept the mask. Other explanations
were ‘patient did not accept mask’, ‘tracheotomy’ and
‘nosebleed’.
Characteristics of study subjects
Patients’ ages ranged from 77 to 93 years versus 55
to 95 years in the BCPAP group versus the conven-
tional treatment group, both with an even gender dis-
tribution. Duration of prehospital treatment ranged
from 20 to 47 min in the BCPAP group and 15 to 87
min in the non-BCPAP group. This was measured as
the interval between arrival of ambulance personnel
at the patients’ location and arrival at the emergency
department.
Eighteen patients are not included in the analysis of
prehospital treatment time because the documentation
of the treatment time was incomplete, i.e. time of arrival
Half upright position
Use Boussignac* mask  
oxygen FiO2 1.0
Syst RR ≥ 90 mmHg
Yes
Nitroglycerin spray 0,4 mg (1 dosis)
No
Furosemide 80 mg i.v.
Effect ≤ 5 min
Nitroglycerin spray 0,4 mg 
(1 dosis) every 5 min 
(if syst RR ≥ 90 mmHg)
Monitor
No
Yes
Syst RR ≥ 90 mmHg
Yes
Nitroglycerin spray 
0,4 mg (1 dosis)
Morfine 2 mg i.v.in 2 min. 
(repeat when necessary
after 5 min.)
No
Breathing sufficient No
Unresponsive
YesRespirate
No
*When patient in coma or not cooperating, 
do not use the Boussignac mask, but consider
bag valve mask ventilation or 
non-rebreathing mask 
Figure 3 National EMS protocol for acute cardiogenic pulmonary edema treatment.
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ment or both were missing on the patients’ ambulance
transport records (Table 1).
Clinical parameters and in-hospital outcomes
In the BCPAP group the median pulse oximetry mea-
sured by the ambulance personnel on arrival at the pa-
tient’s location was 70% and had increased to 95% uponDiagnosis selection: 180
Meet with ACPE 
Criteria: 76
Boussignac mask: 16 No Boussignac mask: 43 
Transfer:3 Missing data: 14 
Figure 4 Flowchart of included patients.arrival at the ED. There was no major change in median
heart rate after BCPAP treatment. Median systolic and
diastolic blood pressure showed a decrease.
In those patients who did not receive BCPAP, the median
pulse oximetry increased from 88% to 95%. The median
heart rate, systolic and diastolic blood pressure decreased
slightly during the conventional prehospital treatment. One
patient who received BCPAP (6%) and three patients who
did not receive BCPAP (7%) were intubated during admis-
sion. In the BCPAP group one patient (6%) was admitted to
the ICU for a total of 53 h and 14 patients (88%) were
transferred to the CCU after evaluation at the ED. Median
length of stay at the CCU was 23 h. In the conventional
treatment group, five patients (12%) were admitted to the
ICU with a median length of stay of 92 h. Twenty-two pa-
tients (54%) were treated at the CCU after evaluation at the
ED. This group had a median length of stay at the CCU of
23 h as well.
Among those patients who survived to hospital discharge,
the length of stay ranged from 1.5 to 20 days, with a
median of 4.6 days, and from 1.5 to 34 days, with a
Table 1 Patients’ characteristics, precipitating factors and prehospital features
Characteristic in median ± IQR
unless otherwise stated
Patients received BCPAP (N = 16
unless otherwise stated)
Patients did not receive BCPAP (N = 43
unless otherwise stated)
p-value
Age, years 85 ±10 84 ± 10 0.26
Male (%) 50 47 0.81
History
History of admission for CHF, % 19 16 1.0
History of ACS, % 38 33 0.72
History of AP, % 25 14 0.44
History of CHF, % 31 37 0.67
History of COPD, % 13 14 1.0
Precipitating factors
AMI with ST elevation, % 0 0 (N = 41) -
AMI without ST elevation, % 31 19 (N = 41) 0.48
No AMI, % 69 77 (N = 41) 0.48
Prehospital features
Pulse oximetry, % 70 ± 22 (N = 13) 88 ±11 (N = 32) 0.002
Heart rate, beats/min 111 ± 28 (N = 11) 110 ± 31 (N = 30) 0.25
Systolic blood pressure, mmHg 169 ± 35 (N = 13) 162 ± 50 (N = 30) 0.60
Diastolic blood pressure, mmHg 104 ± 32 (N = 13) 98 ± 34 (N = 30) 0.58
Prehospital treatment time, min 30 ± 11 (N = 11) 39 ± 20 (N = 30) 0.08
IQR, interquartile range; BCPAP, Boussignac continuous positive airway pressure; CHF, congestive heart failure; ACS, acute coronary syndrome; AP, angina pectoris;
COPD, chronic obstructive pulmonary disease; AMI, acute myocardial infarction; ED, emergency department. When data are missing, this is stated in the table.
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ment group, respectively. Two patients who received
BCPAP (12.5%) and four patients who did not receive
CPAP (9.3%) died during admission.
The groups were comparable with regard to demo-
graphics, precipitating factors and prehospital vital
signs, except for the median pulse oximetry mea-
sured by the ambulance personnel upon arrival at
the patient’s location, which was significantly lower
for the BCPAP group (p = 0.002). Characteristics are
summarised in Tables 1 and 2.
Discussion
Our observational study showed that a significant portion
of patients with evident signs of acute cardiogenic pulmon-
ary edema within the prehospital setting did not receive
BCPAP according to protocol. Only a minority of eligible
patients received the BCPAP treatment from the EMS
personnel. Moreover, only in 16 per cent of cases that did
not receive BCPAP was a documented reason found. No
complications were reported pertaining to the use of the fa-
cial mask.
The benefits of CPAP treatment for ACPE are well
established in the emergency eepartment and ICU,
showing significant improvement of vital parameters
and reduction in endotracheal intubations, ICU/CCU
admissions and mortality [1].The Boussignac CPAP system is a compact and easy to
use system, the feasibility and effectiveness of which
within the prehospital setting have been shown in several
studies [2-4]. Several studies reported that early treatment
of ACPE using BCPAP reduced the number of endo-
tracheal intubations and decreased ICU, CCU and hospital
lengths of stay [5,9-13].
Even though this study did not focus on evaluating out-
come parameters of the BCPAP, we present these parame-
ters in Table 2. There are insufficient data in this study to
report difference in outcome. It is unclear if the outcomes
observed reflect efficacy of the BCPAP versus no BCPAP,
as the study did not aim to establish improvement in out-
come. However, future studies in our population should be
designed to assess whether outcome differences exist.
The EMS organisations in The Hague region implemented
the BCPAP system in their standard protocol for treat-
ment of ACPE. This observational study evaluated the
use, effects and complications of BCPAP treatment by EMS
personnel.
It is well known that ACPE is difficult to diagnose.
Generally, differentiation between clinical signs of COPD
and ACPE is considered to be difficult. When clinical
signs were not obvious upon admission, the diagnosis
ACPE was often supported by ancillary tests. However,
we chose to exclusively include patients on clinical
grounds, without benefit of chest radiography or laboratory
Table 2 Patients’ treatment and in-hospital outcomes
Characteristic in median ± IQR
unless otherwise stated
Patients received BCPAP
(N = 16 unless otherwise stated)
Patients did not receive BCPAP
(N = 43 unless otherwise stated)
Treatment prehospital
Furosemide, % 100 63 (N = 37)
GTN sublingually, % 88 (N = 15) 47 (N = 34)
Intubation, % 0 0 (N = 39)
In-hospital outcomes
Pulse oximetry, % 95 ± 11 95 ± 7 (N = 38)
Heart rate, beats/min 114 ± 35 98 ± 33
Systolic blood pressure, mmHg 160 ± 40 151 ± 49 (N = 41)
Diastolic blood pressure, mmHg 86 ± 19 80 ± 33 (N = 41)
O2 content first ABG, % 97 ± 6 96 ± 6 (N = 29)
paCO2 in first ABG, kPa 6.2 ± 2.8 5.9 ± 2.1 (N = 29)
paO2 in first ABG, kPa 12.1 ± 20 11.3 ± 4.2 (N = 29)
pH in first ABG 7.3 ± 0.1 7.3 ± 0.1 (N = 29)
Intubation, % 6.3 7.0 (N = 41)
Admission to ICU, % 6.3 12 (N = 42)
Length of stay ICU, hours 53 (N = 1) 24 ± 196 (N = 5)
Admission CCU, % 88 54 (N = 42)
Length of stay CCU, hours 23 ± 13 (N = 14) 23 ±32 (N = 22)
Length of stay total, days 4.6 ± 3.9 (N = 15) 5.1 ±7.3 (N = 39)
In-hospital mortality,% 12.5 9.3
IQR, inter quartile range; BCPAP, Boussignac continuous positive airway pressure; GTN, glyceryl trinitrate; ABG, arterial blood gas; CCU = coronary care unit.
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studies suggested that diagnosis of ACPE in the prehospital
setting is too difficult for EMS paramedics. Templier et al.
studied the identification of ACPE by trained emergency
nurses and physicians. The results show that nurses can
recognise ACPE equally well as physicians, who correctly
diagnosed ACPE in 77% of cases [4].
It is unclear why a significant portion of cases did not re-
ceive BCPAP treatment according to protocol in our study.
A documented reason for not complying with the protocol
was only given in 16 per cent of cases. Since the study
period was shortly after the introduction, it is tempting to
suggest that EMS personnel were not familiar with the
treatment, or used the mask for the more severely hypoxic
patients, as the median pulse oximetry in the BCPAP group
was significantly lower. This could mean that a more inten-
sive training programme is warranted to increase the use of
BCPAP. EMS personnel also claimed that the mask caused
discomfort for the patient and inconvenience when admin-
istering glyceryl trinitrate sublingually, as the mask has a
tight fit. Regarding the mask causing discomfort, EMS para-
medics affirm experiencing fewer problems when they
made an effort to prepare and coach the patient to leave
the mask in place. In some cases application was not pos-
sible as described in the results, but no complications were
noted during treatment with the Boussignac mask.Limitations
The present study has several limitations. Firstly,
data were collected retrospectively. Through stated
criteria of inclusion, based on established criteria, we
ensured an accurate selection of patients [1]. Se-
condly, we compared patient characteristics of cases
that were actually treated in conformity with the
BCPAP protocol and cases that did not receive BCPAP
treatment. The factors contributing to the decision to
treat patients using BCPAP are largely unknown.
Therefore, we cannot exclude ascertainment biases in
this analysis. Thirdly, the study contains a limited num-
ber of patients.Conclusion
A significant portion of patients with clinical signs of
acute cardiogenic pulmonary edema in the prehospital
setting is not treated according to protocol using
BCPAP. No complications were reported pertaining to
using the BCPAP system. Based on the small group of
patients that actually received BCPAP treatment, the
facial mask seems feasible and effective for the treatment
of acute cardiogenic pulmonary edema in the prehospital
setting. These findings require confirmation in a larger
prospective study.
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